卵圆孔未闭封堵术或抗血小板治疗用于隐源性卒中 - Suppr

Suppr

超能文献

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

出版信息

N Engl J Med. 2020 Mar 5;382(10):978. doi: 10.1056/NEJMx200001. Epub 2020 Feb 10.

DOI:10.1056/NEJMx200001

PMID:32040904

Abstract

摘要

相似文献

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

N Engl J Med. 2020 Mar 5;382(10):978. doi: 10.1056/NEJMx200001. Epub 2020 Feb 10.

Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.

Int J Stroke. 2017 Dec;12(9):998-1004. doi: 10.1177/1747493017701152. Epub 2017 Mar 24.

close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.

Int J Stroke. 2016 Aug;11(6):724-32. doi: 10.1177/1747493016643551. Epub 2016 Apr 7.

Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?

Am J Med. 2016 Nov;129(11):1159-1162. doi: 10.1016/j.amjmed.2016.08.006. Epub 2016 Aug 24.

Closure of patent foramen ovale in "cryptogenic" stroke: Has the story come to an end?

Int J Stroke. 2018 Apr;13(3):240-242. doi: 10.1177/1747493017751243. Epub 2018 Jan 4.

Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.

Curr Neurol Neurosci Rep. 2018 Oct 17;18(12):92. doi: 10.1007/s11910-018-0910-y.

Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.

Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8.

Patent foramen ovale and cryptogenic stroke: the hole story.

Stroke. 2013 Sep;44(9):2676-8. doi: 10.1161/STROKEAHA.113.001676. Epub 2013 Aug 1.

Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.

Cerebrovasc Dis. 2018;45(3-4):162-169. doi: 10.1159/000487959. Epub 2018 Mar 29.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

引用本文的文献

Optimal Antithrombotic Regimen After Cryptogenic Stroke: A Systematic Review and Network Meta-Analysis.

Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241309639. doi: 10.1177/10760296241309639.

Right Atrial Septal In Situ Microthrombus: A Potential Novel Cause of Patent Foramen Ovale-Associated Stroke.

J Am Heart Assoc. 2024 Nov 19;13(22):e035838. doi: 10.1161/JAHA.124.035838. Epub 2024 Nov 7.

European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke.

Eur Stroke J. 2024 Dec;9(4):800-834. doi: 10.1177/23969873241247978. Epub 2024 May 16.

Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system.

EuroIntervention. 2022 May 15;18(1):68-70. doi: 10.4244/EIJ-D-21-01021.

Cardiac metastasis causes paradoxical malignant embolism.

Cancer Rep (Hoboken). 2022 May;5(5):e1513. doi: 10.1002/cnr2.1513. Epub 2021 Jul 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验